Dr. CKII.

Lâm Quốc Trung

Deputy Head of the Department of Cancer Chemotherapy

Rating:

0/5

(0 rating)

Booking

Rating:

0/5

(0 rating)

Booking

Professional philosophy

In my medical career journey, I always hold the belief: "Treat with intelligence, care with heart". For me, cancer patients need not only a treatment regimen but also a solid spiritual support. I continuously update modern medical advances to provide the best living opportunity for patients. However, above all is empathy and dedicated companionship, because the ultimate goal is not only to extend lifespan but also quality of life and to light hope for each life.

Schedule

HÓA TRỊ

Sáng thứ năm

Patient's feeling

0/5

(0 rating)

Write your review

Rating:

Choose rating

Patient rating

No review

Expertise

Ung bướu

Language

English

Education

2019: Specialist doctor level II in Oncology, University Medical Center Ho Chi Minh City.

2012: Specialist doctor level I in Oncology, University Medical Center Ho Chi Minh City.

2001: General practitioner, Training and Development Center for Medical Officers, Ho Chi Minh City.

Experience

Kinh nghiệm giảng dạy

2024 - 2025: Visiting lecturer in Hematology at University Medical Center Ho Chi Minh City.

Kinh nghiệm khám, chữa bệnh

2021 - present: Deputy Head of Oncology Chemotherapy Department, University of Medicine and Pharmacy Hospital, Ho Chi Minh City.
2014 - 2020: Treating physician at Oncology Chemotherapy Department, University of Medicine and Pharmacy Hospital, Ho Chi Minh City.
2008 - 2013: Deputy Head of Oncology Department, Thong Nhat Hospital.
2007 - 2010: Worked at Oncology Division, Thong Nhat Hospital.
2001 - 2006: Treating physician, Internal Medicine Department, Thong Nhat Hospital.

Associations

Member of the executive board of the Ho Chi Minh City Cancer Society and the Ho Chi Minh City Gastrointestinal Surgery Society
Vice President of the Ho Chi Minh City Cancer Immunotherapy Society.

Research

2020 Đánh giá kết quả điều trị phác đồ EOX trên bệnh nhân ung thư dạ dày tiến xa không phẫu thuật được hoặc di căn - Trường Đaị học Y Dược Tp.HCM 2019~
2020 So sánh tiên lượng sống còn sau khi bệnh tiến triển của bệnh nhân ung thư phổi không tế bào nhỏ có đột biến EGFR giai đoạn tiến xa đã được điều trị bước đầu bằng osimertinib hoặc EGFR -TKI chuẩn - Tạp chí Y học Việt Nam tập 484- tháng 11- số 1-2019
2025 BONE MARROW INFILTRATION WITH ANEMIA AND THROMBOCYTOPENIA, RARE INITIAL SYMPTOMS OF BREAST CANCER
2025 Psychosocial Support Needs and Associated Factors among Cancer Patients: A Hospital-Based, Single-Center Cross-Sectional Study in Vietnam
2025 Preoperative chemotherapy with a modified docetaxel, cisplatin and S-1 regimen, followed by gastrectomy and lymphadenectomy for gastric cancer with bulky lymph nodes